PTC Therapeutics Closes Acquisition of the ST-920 Gene Therapy for Fabry Disease
MT newswire2026/09/21 20:54Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Market Is Primed for a ‘Face Ripper' Rally Thanks to Four Ingredients Says Tom Lee
Federal Reserve tariff refund survey: Enterprises prefer "hoarding cash" rather than investing or lowering prices, casting doubt on the economic stimulus effect
A Federal Reserve study found that most companies retain tariff rebate funds.
Crypto prices
More
